financetom
Business
financetom
/
Business
/
Pegasystems Receives FedRAMP High Status for Generative AI Offerings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pegasystems Receives FedRAMP High Status for Generative AI Offerings
Jun 25, 2025 7:18 AM

09:51 AM EDT, 06/25/2025 (MT Newswires) -- Pegasystems ( PEGA ) said Wednesday it has achieved FedRAMP High Authority to Operate status for its generative artificial intelligence offerings.

The designation, showing the technology has met the government's highest security and compliance standards, allows Pega Cloud for Government users to deploy the company's generative AI-powered offerings, Pegasystems ( PEGA ) said.

The company said the designation also applies to the latest cloud architecture improvements supporting Pega Cloud for Government that allow automatic scaling during peak demand periods and faster application updating when necessary.

Shares of Pegasystems ( PEGA ) were 1.3% higher in recent trading.

Price: 52.30, Change: +0.69, Percent Change: +1.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: 3M Approves Spinoff of Health Care Business
--Street Color: 3M Approves Spinoff of Health Care Business
Mar 8, 2024
12:21 PM EST, 03/08/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 94.07, Change: +1.45, Percent...
What's Going On With Psyence Biomedical Stock?
What's Going On With Psyence Biomedical Stock?
Mar 8, 2024
Psyence Biomedical Ltd. ( PBM ) shares are racing higher Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study. The Details: On Wednesday, Psyence Biomedical ( PBM ) announced the approval for its Phase IIb study to examine the use of psilocybin as a treatment for Adjustment Disorder...
Why Bio-Path Holdings Shares Are Falling Today
Why Bio-Path Holdings Shares Are Falling Today
Mar 8, 2024
Bio-Path Holdings, Inc. ( BPTH )  shares are falling on Friday. The company reported fourth-quarter earnings per share of $4.23 loss, narrower than the estimate of $5.40 loss.  Bio-Path ( BPTH ) reported a net loss of $33.63 per share for the year ended Dec. 31, 2023, lower than $38.12 per share in the year-ago period. Research and development expense for the...
3M Board Approves Planned Spin-off of Health Care Business
3M Board Approves Planned Spin-off of Health Care Business
Mar 8, 2024
12:17 PM EST, 03/08/2024 (MT Newswires) -- 3M ( MMM ) said Friday its board approved the planned spin-off of its health care business, which will be known as Solventum. Solventum, expected to separate on April 1, has applied to list on the New York Stock Exchange under the SOLV ticker. 3M ( MMM ) shareholders will receive one share...
Copyright 2023-2026 - www.financetom.com All Rights Reserved